Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors

Molecular Diversity

Volumn 15, Issue 4, 2011, Pages 979-987

  Chavan, Swapnil ^a   Bhayye, Sagar ^a   Sobhia, M Elizabeth ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Carbocyclic inhibitors; CoMFA; Molecular dynamics; Neuraminidase

Indexed keywords

SIALIDASE; SIALIDASE INHIBITOR; ZANAMIVIR;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; COMPARATIVE MOLECULAR FIELD ANALYSIS; CONTROLLED STUDY; DRUG INTERACTION; DRUG PROTEIN BINDING; DRUG STRUCTURE; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; VALIDATION PROCESS;

ENZYME INHIBITORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; LEAST-SQUARES ANALYSIS; MOLECULAR DYNAMICS SIMULATION; NEURAMINIDASE; PROTEIN CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS; ZANAMIVIR;

EID: 84855250609     PISSN: 13811991     EISSN: 1573501X     Source Type: Journal    
DOI: 10.1007/s11030-011-9332-3     Document Type: Article

References (34)

1. De Clercq E (2006) Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 5: 1015-1025. doi:10.1038/nrd2175 (Pubitemid 44835128)
2. Janakiraman MN, White CL, Laver WG, Air GM, Luo M (1994) Structure of Influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-. ANG. Resoluton: implications for the catalytic mechanism. Biochem 33: 8172-8179. doi:10.1021/bi00193a002 (Pubitemid 24241049)
3. Chong AKJ, Pegg MS, Taylor NR, Itzstein M (1992) Evidence for a sialosyl cation transition state complex in the reaction of sialidase from influenza virus. Eur J Biochem 207: 335-343. doi:10.1111/j. 1432-1033.1992.tb17055.x
4. Taylor NR, ItzsteinM (1994) Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis. J Med Chem 37: 616-624. doi:10.1021/jm00031a011 (Pubitemid 24102181)
5. von Itzstein M, vonWu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363: 418-423. doi:10.1038/363418a0 (Pubitemid 23179386)
6. Thompson JD, Higgins DG, Gibson TJ (1994) Improved sensitivity of profile searches through the use of sequence weights and gap excision. Comput Appl Biosci 10:19-29. doi:10.1093/bioinformatics/10.1.19 (Pubitemid 24066806)
7. Xu X, Zhu X, Dwek RA, Stevens J, Wilson IA (2008) Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol 82: 10493-10501. doi:10.1128/JVI.00959-08 (Pubitemid 352691147)
8. Tisdale M, Daly J, Gor D (2001) Methods for determining resistance to neuraminidase inhibitors. Int Congr Ser 1219: 879-886. doi:10.1016/S0531- 5131(01)00656-2
9. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, Walker PA, Skehel JJ, Martin SR, Hay AJ, Gamblin SJ (2008) Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nat 453:1258. doi:10.1038/nature06956 (Pubitemid 351913590)
10. Garcia-Sosa AT, Sild S, Maran U (2008) Design of multi-bindingsite inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivirresistantH274Y variant. J Chem Inf Model 48: 2074-2080. doi:10. 1021/ci800242z
11. Du QS, Wang SQ, Chou KC (2007) Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Commun 362: 525-531. doi:10.1016/j.bbrc.2007.08.025 (Pubitemid 47332441)
12. de Jong MD, Cam BV, Qui PT, Hien VM, Thanh TT, Hue NB et al (2005) Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 352:686-691 (Pubitemid 40239216)
13. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nat 443: 45-49. doi:10.1038/nature05114 (Pubitemid 44344043)
14. Cramer RD III, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110: 5959-5967. doi:10.1021/ja00226a005
15. Waller CL, Oprea TI, Giolitti A, Marshall GR (1993) Threedimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules. J Med Chem 36: 4152-4160. doi:10.1021/jm00078a003 (Pubitemid 24037924)
16. Yasuo K, Yamaotsu N, Gouda H, Tsujishita H, Hirono S (2009) Structure-based CoMFA as a predictive model-CYP2C9 inhibitors as a test case. J Chem Inf Model 49: 853-864. doi:10. 1021/ci800313h
17. Case DA, Cheatham TE III, Darden T, Gohlke H, Luo R, Merz KM Jr, Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26: 1668-1688. doi:10.1002/jcc.20290 (Pubitemid 43076180)
18. Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA (1995) A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 117: 5179-5197. doi:10.1021/ja00124a002
19. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25: 1157-1174. doi:10.1002/jcc.20035
20. Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25: 247-260. doi:10.1016/j.jmgm.2005. 12.005 (Pubitemid 44363172)
21. Zhou R (2003) Free energy landscape of protein folding in water: explicit vs. implicit solvent. Proteins Struct Funct Genet 53: 148-161. doi:10.1002/prot.10483 (Pubitemid 37193811)
22. Lee MS, Salsbury FR Jr, Olson MA (2004) An efficient hybrid explicit/implicit solvent method for biomolecular simulations. J Comput Chem 25: 1967-1978. doi:10.1002/jcc.20119
23. Cheatham TE III, Miller JL, Fox T, Darden TA, Kollman PA (1995) Molecular dynamics simulations on solvated biomolecular systems: the particle mesh Ewald method leads to stable trajectories of DNA, RNA, and proteins. J AmChem Soc 117: 4193-4194. doi:10.1021/ja00119a045
24. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926. doi:10.1063/1.445869
25. Masukawa KM, Kollman PA, Kuntz ID (2003) Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations. J Med Chem 46: 5628-5637. doi:10. 1021/jm030060q (Pubitemid 37543314)
26. Kim CU, Lew W, Williams MA, Wu H, Zhang L, Chen X, Escarpe PA, Mendel DB, Laver WG, Stevens RC (1998) Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. J Med Chem 41: 2451-2460. doi:10.1021/jm980162u (Pubitemid 28321896)
27. SYBYL7.1, Tripos Associates Inc.: 1699, S Hanley Rd., St. Louis, MO631444
28. Raghavan K, Buolamwini JK, Fesen MR, Pommier Y, Kohn KW, Weinstein JN (1995) Three-dimensional quantitative structure- activity relationship (QSAR) of HIV integrase inhibitors: a comparativemolecular field analysis (CoMFA) study. J Med Chem 38: 890-897. doi:10.1021/jm00006a006
29. Clark M, Cramer RD III, Van Opdenbosch N (1989) Validation of the general purpose Tripos 5.2 force field. J Comput Chem 10: 982-1012. doi:10.1002/jcc.540100804
30. Cramer RD III, Bunce JD, Patterson DE, Frank IE (1988) Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant Struct Act Relatsh 7: 18-25. doi:10.1002/qsar.19880070105
31. Afantitis A, Melagraki G, Sarimveis H, Koutentis PA, Igglessi-Markopoulou O, Kollias G (2009) A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs. Mol Divers 14: 225-235. doi:10.1007/s11030-009-9163-7
32. GolbraikhA, TropshaA (2002) Beware of q2!. J Mol Graph Model 20: 269-276. doi:10.1016/S1093-3263(01)00123-1 (Pubitemid 34017544)
33. Aboye TL, SobhiaME, Bharatam PV (2004) 3D-QSAR studies of pyruvate dehydrogenase kinase inhibitors based on a divide and conquer strategy* 1. Bioorg Med Chem 12: 2709-2715. doi:10. 1016/j.bmc.2004.03.019 (Pubitemid 38542795)
34. Zheng M, Yu K, Liu H, Luo X, Chen K, Zhu W, Jiang H (2006) QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR. J Comput Aided Mol Des 20: 549-566. doi:10.1007/s10822-006-9080-0 (Pubitemid 44823891)